KIMBERLY CLARK Q2 FY26 earnings call KMB

The company experienced a significant disruption in its China diaper business, primarily in the back half of June, which caused Q2 organic sales to be approximately 100 basis points below internal expectations. This issue stems from social media claims, though the company asserts multiple independent tests confirm product safety. Management is cooperating with Chinese authorities and investing aggressively in communication to reinforce product facts. While no sequential deterioration in sellout has been observed, a positive inflection has not yet occurred, leading to a cautious outlook for the balance of the year, with an estimated $70 million operating profit and $0.16 EPS headwind in H2 FY26.

North America consumer categories saw shipments lag consumption by about 170 basis points in Q2, with shipments down 1.4% versus 0.3% consumption growth. This was primarily driven by an 80 basis point headwind from the L.A. distribution center fire and a 100 basis point impact from retailer inventory movements, half of which was unanticipated and concentrated in adult care. For the first half, shipments lagged consumption by 200 basis points due to the fire, inventory movements, and heightened activation programming. Management expresses confidence in H2 acceleration due to a strong innovation pipeline, brand investments, revenue growth management actions, and easier prior-year comparisons.

Kimberly-Clark highlighted its robust innovation pipeline, describing it as the most commercially active in recent history, with even stronger innovations anticipated in the coming years. The company unveiled a proprietary alternative natural fiber innovation program, which is the culmination of over two decades of R&D. This new fiber is expected to enhance product performance (superior softness and strength), benefit the planet (farm crop replacing natural forest fiber, land-efficient, water-miser), and improve economics (potential for enhanced margins and reduced volatility). A pilot facility is being built, and land has been acquired, with investments already factored into strategic plans.

The integration planning for the Kenvue acquisition is progressing well, with management expressing increased confidence in achieving the previously announced $1.9 billion cost synergy target. While it's too early to provide a specific 2027 outlook, the company remains confident in the underlying earnings power and growth potential of the combined entity. Management noted that the consumer health categories on the Kenvue side offer significant growth opportunities due to a gap between health issue incidence and treatment, which can be expanded through category-building programs.

The promotional environment in North America is noted to be increasing slightly from both branded competitors and smaller players. Kimberly-Clark's strategy focuses on compelling value propositions, PNOC (Price, Net of Cost) discipline, and innovation rather than excessive promotion, which they believe does not grow the category. The company's total pricing was down 50 basis points in H1 FY26 due to temporary promotions, targeted revenue growth management, and channel mix shifts. Low single-digit pricing actions are planned for H2 FY26, primarily in North America, to cover inflation.

The company faced approximately $50 million in inflationary headwinds in Q2, mainly from higher oil-linked input costs and impacts from the L.A. distribution center fire. For H2 FY26, a gross input cost headwind of around $150 million is anticipated, based on oil prices at $100 per barrel. However, through a combination of mitigating actions already underway and the $45 million tariff refund received in Q2, Kimberly-Clark expects to fully offset these incremental costs and maintain pricing net of cost inflation at roughly neutral levels for the full year.